![](https://assets.cambridge.org/97805215/76468/cover/9780521576468.jpg)
Book contents
- Frontmatter
- Contents
- List of Tables
- List of Figures
- List of Boxes
- Acknowledgments
- 1 Introduction
- 2 Evidence of effectiveness: evaluating its quality
- 3 Utility assessment for estimating quality-adjusted life years
- 4 Measuring costs
- 5 From cost–effectiveness ratios to resource allocation: where to draw the line?
- 6 Valuing health care benefits in money terms
- 7 Discounting health effects for medical decisions
- 8 Statistical issues in cost–effectiveness analyses
- 9 Decision trees and Markov models in cost–effectiveness research
- 10 The use of cost–effectiveness/cost–benefit analysis in actual decision making: current status and prospects
- Notes
- References
- Index
Contents
Published online by Cambridge University Press: 07 December 2009
- Frontmatter
- Contents
- List of Tables
- List of Figures
- List of Boxes
- Acknowledgments
- 1 Introduction
- 2 Evidence of effectiveness: evaluating its quality
- 3 Utility assessment for estimating quality-adjusted life years
- 4 Measuring costs
- 5 From cost–effectiveness ratios to resource allocation: where to draw the line?
- 6 Valuing health care benefits in money terms
- 7 Discounting health effects for medical decisions
- 8 Statistical issues in cost–effectiveness analyses
- 9 Decision trees and Markov models in cost–effectiveness research
- 10 The use of cost–effectiveness/cost–benefit analysis in actual decision making: current status and prospects
- Notes
- References
- Index
Summary
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Abook%3A9780511625817/resource/name/firstPage-9780511625817toc_pv-vii_CBO.jpg)
- Type
- Chapter
- Information
- Valuing Health CareCosts, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies, pp. v - viiPublisher: Cambridge University PressPrint publication year: 1995